ENTITY
InnoCare Pharma Ltd

InnoCare Pharma Ltd (9969 HK)

68
Analysis
Health CareChina
InnoCare Pharma Limited researches, develops, manufactures, and distributes pharmaceuticals. The Company produces antibiotic drugs, respiratory drugs, cardiovascular drugs, vitamin tablets, health care drugs, and other related products. InnoCare Pharma markets its products throughout China.
more
Refresh
15 Mar 2020 13:26

ECM Weekly (15 Mar 2020) - SBI Cards, SCG Package, Innocare, Akesobio, Zhenro Services

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Asia IPOs...

Share
13 Mar 2020 14:16

InnoCare (诺诚健华) IPO: Bifurcated Book, Update of Our View

InnoCare launched the book building on March 11th to raise up to USD 288 million to list in Hong Kong. Book building will end on March 16...

Logo
435 Views
Share
11 Mar 2020 16:48

InnoCare Pharma IPO: Valuation Easy to Swallow

InnoCare Pharma Ltd (9969 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
468 Views
Share
11 Mar 2020 14:39

InnoCare (诺诚健华) IPO: Momentum Matters but Mind the Limited Upside

InnoCare launched book building to raise up to USD 288 million to list in Hong Kong. In our previous notes, we have covered the company’s key...

Logo
403 Views
Share
04 Mar 2020 13:24

InnoCare (诺诚健华) Pre-IPO: PHIP and Valuation Update

InnoCare Pharma Limited is a clinical-stage biopharmaceutical company with a focus on small molecule inhibitors for BTK, and FGFRs. The company...

Logo
481 Views
Share
x